AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
After a whole year of just performing like trash, XBI is now at covid levels. It literally gave up all the gains it made in 2020 in 2021.
It is currently at a monthly SR level and volume area, while also being at the long term trendline. I'm expecting this to turn around and at least hit ~$115 again, but who knows, it's the XBI after all.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。